Prof Jason M. Mwenda is a public health specialist currently the Regional Co-ordinator responsible for co-ordinating surveillance for Vaccine Preventable Diseases in the Africa. He co-ordinates surveillance for paediatric diarrhea, invasive pneumococcal diseases (IPD), meningitis and pneumonia in children. This involves providing guidance to countries and support for evidence-based decision making to support introduction and monitoring impact of new and under-utilized vaccines in Africa. These countries are now using established regional sentinel hospital-based surveillance system to evaluate the impact of new vaccines on meningitis and pneumonia hospitalizations including the safety signals during the Malaria Vaccine Implementation Project (MVIP). He has published 253 scientific publications in peer international reviewed journals, contributed book chapters and has been guest editor and has co-ordinated publication of six special journal supplements on Rotavirus disease burden and impact of rotavirus and pneumococci conjugate Vaccines (PCV) vaccination in Africa including a journal supplement “Early Impact of pneumococci conjugate Vaccines (PCV) in Africa, Clinical Infectious Diseases (CID), 15 September 2019. Prof Mwenda is also currently co-ordinating monitoring of COVID-19 vaccine effectiveness (AFRO-MoVE), a recently established network comprising of 21 countries to support vaccine effectiveness (VE) studies and SARS-CoV-2 variants genomic surveillance monitoring as part of COVID-19 pandemic response.